{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T08:54:45Z","timestamp":1781859285992,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T00:00:00Z","timestamp":1696550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T00:00:00Z","timestamp":1696550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s40123-023-00819-5","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T14:01:34Z","timestamp":1696600894000},"page":"3307-3322","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparative Effectiveness and Safety of Two Different Trabecular MIGS Devices With and Without Ab Interno Canaloplasty in Patients with Primary Open-Angle Glaucoma"],"prefix":"10.1007","volume":"12","author":[{"given":"Mitchell","family":"Shultz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Chorbajian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ala","family":"Zohouralen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,6]]},"reference":[{"key":"819_CR1","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"Y-CC Tham","year":"2014","unstructured":"Tham Y-CC, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121:2081\u201390.","journal-title":"Ophthalmology"},{"key":"819_CR2","doi-asserted-by":"publisher","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","volume":"5","author":"SR Flaxman","year":"2017","unstructured":"Flaxman SR, Bourne RRA, Resnikoff S, et al. Global causes of blindness and distance vision impairment 1990\u20132020: a systematic review and meta-analysis. Lancet Glob Health. 2017;5:e1221\u201334.","journal-title":"Lancet Glob Health"},{"key":"819_CR3","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0002-9394(98)00223-2","volume":"126","author":"Collaborative Normal-Tension Glaucoma Study Group","year":"1998","unstructured":"Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol. 1998;126:487\u201397.","journal-title":"Am J Ophthalmol"},{"key":"819_CR4","doi-asserted-by":"publisher","DOI":"10.1097\/01.ijg.0000151683.04410.f3","author":"B Bengtsson","year":"2005","unstructured":"Bengtsson B, Heijl A. A long-term prospective study of risk factors for glaucomatous visual field loss in patients with ocular hypertension. J Glaucoma. 2005. https:\/\/doi.org\/10.1097\/01.ijg.0000151683.04410.f3. (Epub ahead of print April 2005).","journal-title":"J Glaucoma"},{"key":"819_CR5","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1016\/S0161-6420(99)90497-9","volume":"106","author":"MC Leske","year":"1999","unstructured":"Leske MC, Heijl A, Hyman L, et al. Early manifest glaucoma trial: design and baseline data. Ophthalmology. 1999;106:2144\u201353.","journal-title":"Ophthalmology"},{"key":"819_CR6","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","volume":"311","author":"RN Weinreb","year":"2014","unstructured":"Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma. JAMA. 2014;311:1901.","journal-title":"JAMA"},{"key":"819_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1477-7525-1-75","volume":"1","author":"J-P Nordmann","year":"2003","unstructured":"Nordmann J-P, Auzanneau N, Ricard S, et al. Vision related quality of life and topical glaucoma treatment side effects. Health Qual Life Outcomes. 2003;1:75.","journal-title":"Health Qual Life Outcomes"},{"key":"819_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.749858","author":"T Wang","year":"2021","unstructured":"Wang T, Cao L, Jiang Q, et al. Topical medication therapy for glaucoma and ocular hypertension. Front Pharmacol. 2021. https:\/\/doi.org\/10.3389\/fphar.2021.749858. (Epub ahead of print 1 December 2021).","journal-title":"Front Pharmacol"},{"key":"819_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/08164622.2021.1964331","volume":"105","author":"A Arbabi","year":"2022","unstructured":"Arbabi A, Bao X, Shalaby WS, et al. Systemic side effects of glaucoma medications. Clin Exp Optom. 2022;105:157\u201365.","journal-title":"Clin Exp Optom"},{"key":"819_CR10","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1055\/s-2008-1027362","volume":"225","author":"C Tappeiner","year":"2008","unstructured":"Tappeiner C, Perren B, Iliev M, et al. Orbitale Fettgewebsatrophie bei lokaler Bimatoprost-Therapie - Kann Bimatoprost einen Enophthalmus verursachen? Klin Monbl Augenheilkd. 2008;225:443\u20135.","journal-title":"Klin Monbl Augenheilkd"},{"key":"819_CR11","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.ajo.2011.10.026","volume":"153","author":"SJ Gedde","year":"2012","unstructured":"Gedde SJ, Schiffman JC, Feuer WJ, et al. Treatment outcomes in the tube versus trabeculectomy (TVT) study after five years of follow-up. Am J Ophthalmol. 2012;153:789-803.e2.","journal-title":"Am J Ophthalmol"},{"key":"819_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/ICU.0b013e32834ff401","volume":"23","author":"S Salim","year":"2012","unstructured":"Salim S. Current variations of glaucoma filtration surgery. Curr Opin Ophthalmol. 2012;23:89\u201395.","journal-title":"Curr Opin Ophthalmol"},{"key":"819_CR13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12886-017-0466-7","volume":"17","author":"K Hirooka","year":"2017","unstructured":"Hirooka K, Nitta E, Ukegawa K, et al. Vision-related quality of life following glaucoma filtration surgery. BMC Ophthalmol. 2017;17:66.","journal-title":"BMC Ophthalmol"},{"key":"819_CR14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/00055735-199904000-00006","volume":"10","author":"NSC Borisuth","year":"1999","unstructured":"Borisuth NSC, Phillips B, Krupin T. The risk profile of glaucoma filtration surgery. Curr Opin Ophthalmol. 1999;10:112\u20136.","journal-title":"Curr Opin Ophthalmol"},{"key":"819_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ajo.2006.07.022","volume":"143","author":"SJ Gedde","year":"2007","unstructured":"Gedde SJ, Herndon LW, Brandt JD, et al. Surgical complications in the tube versus trabeculectomy study during the first year of follow-up. Am J Ophthalmol. 2007;143:23-31.e2.","journal-title":"Am J Ophthalmol"},{"key":"819_CR16","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.2147\/OPTH.S135316","volume":"11","author":"LE Pillunat","year":"2017","unstructured":"Pillunat LE, Erb C, J\u00fcnemann AG, et al. Micro-invasive glaucoma surgery (MIGS): a review of surgical procedures using stents. Clin Ophthalmol. 2017;11:1583\u2013600.","journal-title":"Clin Ophthalmol"},{"key":"819_CR17","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.survophthal.2020.09.005","volume":"66","author":"P Nichani","year":"2021","unstructured":"Nichani P, Popovic MM, Schlenker MB, et al. Microinvasive glaucoma surgery: a review of 3476 eyes. Surv Ophthalmol. 2021;66:714\u201342.","journal-title":"Surv Ophthalmol"},{"key":"819_CR18","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2147\/OPTH.S239772","volume":"14","author":"JA Rosdahl","year":"2020","unstructured":"Rosdahl JA, Gupta D. Prospective studies of minimally invasive glaucoma surgeries: systematic review and quality assessment. Clin Ophthalmol. 2020;14:231\u201343.","journal-title":"Clin Ophthalmol"},{"key":"819_CR19","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1080\/08820538.2021.1903513","volume":"36","author":"FA Birnbaum","year":"2021","unstructured":"Birnbaum FA, Neeson C, Sol\u00e1-Del VD. Microinvasive glaucoma surgery: an evidence-based review. Semin Ophthalmol. 2021;36:772\u201386.","journal-title":"Semin Ophthalmol"},{"key":"819_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/ceo.14048","volume":"50","author":"DP Holmes","year":"2022","unstructured":"Holmes DP, Clement CI, Nguyen V, et al. Comparative study of 2-year outcomes for Hydrus or iStent inject microinvasive glaucoma surgery implants with cataract surgery. Clin Exp Ophthalmol. 2022;50:303\u201311.","journal-title":"Clin Exp Ophthalmol"},{"key":"819_CR21","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ophtha.2019.04.034","volume":"127","author":"IIK Ahmed","year":"2020","unstructured":"Ahmed IIK, Fea A, Au L, et al. A prospective randomized trial comparing Hydrus and iStent microinvasive glaucoma surgery implants for standalone treatment of open-angle glaucoma. Ophthalmology. 2020;127:52\u201361.","journal-title":"Ophthalmology"},{"key":"819_CR22","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1007\/s00417-019-04366-3","volume":"257","author":"AM Davids","year":"2019","unstructured":"Davids AM, Pahlitzsch M, Boeker A, et al. Ab interno canaloplasty (ABiC)\u201412-month results of a new minimally invasive glaucoma surgery (MIGS). Graefe\u2019s Arch Clin Exper Ophthalmol. 2019;257:1947\u201353.","journal-title":"Graefe\u2019s Arch Clin Exper Ophthalmol"},{"key":"819_CR23","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.ophtha.2019.03.006","volume":"126","author":"TW Samuelson","year":"2019","unstructured":"Samuelson TW, Sarkisian SRJ, Lubeck DM, et al. Prospective, randomized, controlled pivotal trial of an ab interno implanted trabecular micro-bypass in primary open-angle glaucoma and cataract: two-year results. Ophthalmology. 2019;126:811\u201321.","journal-title":"Ophthalmology"},{"key":"819_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40662-019-0157-y","volume":"6","author":"S Samet","year":"2019","unstructured":"Samet S, Ong JA, Ahmed IIK. Hydrus microstent implantation for surgical management of glaucoma: a review of design, efficacy and safety. Eye Vis. 2019;6:32.","journal-title":"Eye Vis"},{"key":"819_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-051496","volume":"12","author":"R Hu","year":"2022","unstructured":"Hu R, Guo D, Hong N, et al. Comparison of Hydrus and iStent microinvasive glaucoma surgery implants in combination with phacoemulsification for treatment of open-angle glaucoma: systematic review and network meta-analysis. BMJ Open. 2022;12: e051496.","journal-title":"BMJ Open"},{"key":"819_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131770","volume":"10","author":"MS Malvankar-Mehta","year":"2015","unstructured":"Malvankar-Mehta MS, Iordanous Y, Chen YN, et al. iStent with phacoemulsification versus phacoemulsification alone for patients with glaucoma and cataract: a meta-analysis. PLoS One. 2015;10: e0131770.","journal-title":"PLoS One"},{"key":"819_CR27","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/S0161-6420(03)00227-6","volume":"110","author":"LA Fannin","year":"2003","unstructured":"Fannin LA, Schiffman JC, Budenz DL. Risk factors for hypotony maculopathy. Ophthalmology. 2003;110:1185\u201391.","journal-title":"Ophthalmology"},{"key":"819_CR28","unstructured":"Stephens D. Comparison of 2 different trabecular MIGS devices in patients with mild to moderate open-angle glaucoma. Washington 2022."},{"key":"819_CR29","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41433-019-0459-2","volume":"34","author":"GA Lee","year":"2020","unstructured":"Lee GA, Porter AJ, Vincent RA, et al. Combined phacoemulsification and microinvasive glaucoma surgery in comparison to phacoemulsification alone for open angle glaucoma. Eye. 2020;34:312\u20138.","journal-title":"Eye"},{"key":"819_CR30","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.ophtha.2022.02.021","volume":"129","author":"IIK Ahmed","year":"2022","unstructured":"Ahmed IIK, De Francesco T, Rhee D, et al. Long-term outcomes from the HORIZON randomized trial for a schlemm\u2019s canal microstent in combination cataract and glaucoma surgery. Ophthalmology. 2022;129:742\u201351.","journal-title":"Ophthalmology"},{"key":"819_CR31","first-page":"3641","volume":"14","author":"T Hughes","year":"2020","unstructured":"Hughes T, Traynor M. Clinical results of Ab interno canaloplasty in patients with open-angle glaucoma. Clin Ophthalmol. 2020;14:3641\u201350.","journal-title":"Clin Ophthalmol"},{"key":"819_CR32","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00717-018-0416-7","volume":"32","author":"N K\u00f6rber","year":"2018","unstructured":"K\u00f6rber N. Ab interno canaloplasty for the treatment of glaucoma: a case series study. Spektrum der Augenheilkunde. 2018;32:223\u20137.","journal-title":"Spektrum der Augenheilkunde"},{"key":"819_CR33","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.2147\/OPTH.S215667","volume":"13","author":"M Heersink","year":"2019","unstructured":"Heersink M, Dovich JA. Ab interno canaloplasty combined with trabecular bypass stenting in eyes with primary open-angle glaucoma. Clin Ophthalmol. 2019;13:1533\u201342.","journal-title":"Clin Ophthalmol"},{"key":"819_CR34","doi-asserted-by":"publisher","first-page":"4881","DOI":"10.3390\/jcm10214881","volume":"10","author":"K Go\u0142aszewska","year":"2021","unstructured":"Go\u0142aszewska K, Konopi\u0144ska J, Obuchowska I. Evaluation of the efficacy and safety of canaloplasty and iStent bypass implantation in patients with open-angle glaucoma: a review of the literature. J Clin Med. 2021;10:4881.","journal-title":"J Clin Med"},{"key":"819_CR35","unstructured":"Shultz M. Effectiveness and safety of 2 different trabecular MIGS devices in patients with mild to moderate glaucoma. Washington, D.C.: Annual Meeting of the American Society of Cataract and Refractive Surgery (ASCRS) 2022."},{"issue":"4","key":"819_CR36","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1007\/s40123-023-00726-9","volume":"12","author":"MJ Gallardo","year":"2023","unstructured":"Gallardo MJ, Porter M. Efficacy and safety of pairing iStent inject trabecular micro-bypass and iAccess precision blade goniotomy in patients with open-angle glaucoma. Ophthalmol Ther. 2023;12(4):1973\u201387.","journal-title":"Ophthalmol Ther"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-023-00819-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-023-00819-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-023-00819-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T07:20:38Z","timestamp":1699687238000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-023-00819-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["819"],"URL":"https:\/\/doi.org\/10.1007\/s40123-023-00819-5","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,6]]},"assertion":[{"value":"18 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Shultz: Aerie, R; Alchemy Vision, O; Allergan, C; Avellino Lab, C; Bausch and Lomb, C, R, L; BVI, R; Cloud Break, R; Glaukos, C, R, L; Glint Pharma, C; HDMD, C; HDMD, C; Imprimis\/Harrow, C; Ivantis, C, L; New World Medical, C, R; Ocuphire Pharm, C; Sight Sciences, C, L; SOMED, C; SUN Pharm, C; Tarsus, R; Twenty Twenty, C; Zeiss, C. (C, consulting fees; R, research fees; L, lecture fees). Mr. Chorbajian: no competing interests. Ms. Zohouralen: no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was conducted according to the tenets of the Helsinki Declaration of 1964, local ethics guidelines (Western IRB), and HIPAA privacy practices. All patients gave informed consent prior to undergoing surgery, and their data were analyzed in a retrospective anonymized fashion.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}